IndexCopernicus™ Authors Information
Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression.
Robert Z Orlowski, Arnon Nagler, Pieter Sonneveld, Joan Bladé, Roman Hajek, Andrew Spencer, Jesús San Miguel, Tadeusz Robak, Anna Dmoszynska, Noemi Horvath, Ivan Spicka, Heather J Sutherland, Alexander N Suvorov, Sen H Zhuang, Trilok Parekh, Liang Xiu, Zhilong Yuan, Wayne Rackoff, Jean-Luc Harousseau
J Clin Oncol 2007; 25(25):3892-3901
ICID: 592815
IC™ Value: 2.00
Author's profile available for:
  • Anna Dmoszynska - click here